ISOSORBIDE MONONITRATE

ISOSORBIDE MONONITRATE was reported 20954 times

ISOSORBIDE MONONITRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 389 0.6971
1 IMMUNISATION 244 0.5622
2 PALMOPLANTAR KERATODERMA 378 0.5214
3 NEUROGLYCOPENIA 33 0.3000
4 AGITATION POSTOPERATIVE 14 0.2222
5 ATRIAL TACHYCARDIA 393 0.1870
6 PRURITUS GENITAL 386 0.1638
7 CAROTID ARTERY OCCLUSION 391 0.1071
8 CONFUSION POSTOPERATIVE 14 0.1069
9 PERIPHERAL CIRCULATORY FAILURE 38 0.0925
10 SLEEP TERROR 382 0.0906
11 TENSION HEADACHE 385 0.0895
12 GENITAL EROSION 24 0.0808
13 MULTIPLE DRUG THERAPY 50 0.0663
14 FEAR OF EATING 19 0.0613
15 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 14 0.0515
16 VENOUS PRESSURE JUGULAR INCREASED 18 0.0496
17 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 48 0.0452
18 FACIAL PAIN 384 0.0430
19 SUBARACHNOID HAEMORRHAGE 434 0.0426
20 CARDIORENAL SYNDROME 23 0.0401
21 GLASGOW COMA SCALE ABNORMAL 14 0.0386
22 MUCOSAL EROSION 35 0.0385
23 VASCULITIS 404 0.0346
24 HYPERPARATHYROIDISM SECONDARY 84 0.0335
25 AUTOIMMUNE MYOSITIS 15 0.0318
26 NEPHROGENIC ANAEMIA 143 0.0308
27 LEFT ATRIAL DILATATION 39 0.0306
28 VENTRICULAR TACHYCARDIA 474 0.0287
29 ANOSMIA 380 0.0262
30 VENTRICULAR DYSFUNCTION 68 0.0262
31 PERICARDITIS 400 0.0238
32 PRINZMETAL ANGINA 23 0.0231
33 BLOOD CHOLESTEROL DECREASED 43 0.0231
34 GASTRIC POLYPS 50 0.0221
35 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 50 0.0202
36 LEFT VENTRICULAR FAILURE 65 0.0189
37 ATRIOVENTRICULAR BLOCK FIRST DEGREE 79 0.0182
38 ARTERIOSPASM CORONARY 73 0.0182
39 MUSCLE TWITCHING 412 0.0179
40 ANGINA PECTORIS 496 0.0173
41 ANGINA UNSTABLE 107 0.0164
42 DIPLOPIA 412 0.0158
43 REBOUND ACID HYPERSECRETION 46 0.0152
44 END STAGE RENAL DISEASE 264 0.0145
45 PAIN OF SKIN 388 0.0144
46 TRANSIENT ISCHAEMIC ATTACK 465 0.0138
47 STUPOR 43 0.0134
48 LIP SWELLING 445 0.0133
49 BLOOD CREATINE INCREASED 59 0.0133
50 CARDIAC FAILURE CHRONIC 55 0.0129
51 RASH PAPULAR 286 0.0127
52 CORONARY ARTERY STENOSIS 64 0.0127
53 LABELLED DRUG-DRUG INTERACTION ISSUE 18 0.0124
54 HAEMATOCRIT INCREASED 28 0.0123
55 MUCOSAL DRYNESS 24 0.0119
56 EYE PRURITUS 392 0.0117
57 ESSENTIAL TREMOR 13 0.0116
58 RENAL ARTERY STENOSIS 16 0.0116
59 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 37 0.0112
60 VENTRICULAR HYPERTROPHY 28 0.0112
61 SINUS ARREST 17 0.0108
62 COMPLEX PARTIAL SEIZURES 12 0.0108
63 MYOCARDIAL ISCHAEMIA 120 0.0105
64 ANGIOEDEMA 462 0.0104
65 ARTERIOSCLEROSIS CORONARY ARTERY 68 0.0103
66 DERMATITIS EXFOLIATIVE 51 0.0102
67 BLINDNESS 412 0.0101
68 MICROCYTIC ANAEMIA 21 0.0101
69 COGNITIVE DISORDER 471 0.0101
70 CHRONIC FATIGUE SYNDROME 14 0.0100
71 CARDIOACTIVE DRUG LEVEL INCREASED 13 0.0099
72 GLOMERULAR FILTRATION RATE ABNORMAL 14 0.0099
73 ISCHAEMIC CARDIOMYOPATHY 30 0.0098
74 HIRSUTISM 13 0.0098
75 COAGULATION TIME PROLONGED 15 0.0097
76 GASTRITIS EROSIVE 45 0.0096
77 LINEAR IGA DISEASE 16 0.0096
78 ACUTE MYOCARDIAL INFARCTION 283 0.0096
79 CORONARY ARTERY DISEASE 290 0.0096
80 TINNITUS 434 0.0094
81 ANGIOPLASTY 14 0.0094
82 ESSENTIAL HYPERTENSION 17 0.0093
83 CARDIAC FAILURE ACUTE 61 0.0091
84 DUODENITIS 28 0.0091
85 BUNDLE BRANCH BLOCK LEFT 38 0.0090
86 CUTANEOUS LUPUS ERYTHEMATOSUS 17 0.0087
87 HYPERPARATHYROIDISM 18 0.0087
88 PARKINSONISM 83 0.0085
89 BLOOD POTASSIUM INCREASED 138 0.0085
90 COLONIC POLYP 14 0.0085
91 DUODENAL ULCER HAEMORRHAGE 24 0.0084
92 AORTIC STENOSIS 29 0.0083
93 BRADYKINESIA 49 0.0083
94 HYPOVOLAEMIA 48 0.0082
95 IRON DEFICIENCY ANAEMIA 75 0.0081
96 PUPILLARY REFLEX IMPAIRED 15 0.0081
97 DISTURBANCE IN ATTENTION 435 0.0081
98 RENAL FAILURE CHRONIC 62 0.0081
99 BLOOD UREA INCREASED 135 0.0081
100 CHRONIC KIDNEY DISEASE 612 0.0080
101 NORMOCHROMIC NORMOCYTIC ANAEMIA 24 0.0080
102 HYPERKALAEMIA 279 0.0079
103 MELAENA 175 0.0079
104 CORONARY ARTERY OCCLUSION 109 0.0079
105 HYPOMAGNESAEMIA 110 0.0079
106 VASCULAR STENT THROMBOSIS 16 0.0079
107 PEPTIC ULCER 26 0.0078
108 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 17 0.0077
109 BLOOD PHOSPHORUS INCREASED 21 0.0077
110 UPPER GASTROINTESTINAL HAEMORRHAGE 126 0.0075
111 SUSPECTED SUICIDE 35 0.0075
112 HAEMOGLOBIN INCREASED 34 0.0074
113 ACUTE CORONARY SYNDROME 61 0.0074
114 AORTIC VALVE STENOSIS 13 0.0073
115 HAEMORRHAGIC ANAEMIA 32 0.0073
116 HALLUCINATION 546 0.0072
117 AMNESIA 468 0.0072
118 ANXIETY DISORDER 24 0.0072
119 TOXIC EPIDERMAL NECROLYSIS 108 0.0071
120 KOUNIS SYNDROME 16 0.0070
121 INFECTED SKIN ULCER 13 0.0069
122 BLOOD BICARBONATE DECREASED 13 0.0069
123 ORTHOSTATIC HYPOTENSION 119 0.0068
124 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 35 0.0068
125 GASTROINTESTINAL ULCER 15 0.0068
126 HIATUS HERNIA 87 0.0067
127 MITRAL VALVE INCOMPETENCE 76 0.0067
128 STENT PLACEMENT 54 0.0067
129 CHEST PAIN 1239 0.0067
130 SEDATION COMPLICATION 17 0.0067
131 DUODENAL ULCER 47 0.0067
132 BLOOD LOSS ANAEMIA 15 0.0066
133 VENTRICULAR FIBRILLATION 73 0.0066
134 METASTATIC NEOPLASM 28 0.0065
135 DIASTOLIC DYSFUNCTION 20 0.0065
136 PERIPHERAL VASCULAR DISORDER 33 0.0064
137 PRESYNCOPE 155 0.0064
138 HYPONATRAEMIA 359 0.0064
139 RHABDOMYOLYSIS 265 0.0063
140 METABOLIC ENCEPHALOPATHY 19 0.0063
141 ORTHOPNOEA 20 0.0063
142 VASCULAR OCCLUSION 13 0.0061
143 MYOCARDIAL INFARCTION 1072 0.0061
144 CARDIAC FAILURE CONGESTIVE 487 0.0061
145 RENAL FAILURE ACUTE 256 0.0060
146 ACUTE KIDNEY INJURY 921 0.0060
147 VENTRICULAR ARRHYTHMIA 22 0.0060
148 LOWER GASTROINTESTINAL HAEMORRHAGE 44 0.0059
149 COLITIS MICROSCOPIC 28 0.0059
150 SINUS BRADYCARDIA 57 0.0059
151 BRADYCARDIA 312 0.0059
152 CARDIAC FAILURE 471 0.0059
153 DIVERTICULUM INTESTINAL HAEMORRHAGIC 13 0.0058
154 TACHYCARDIA 513 0.0058
155 MICTURITION DISORDER 20 0.0058
156 NON-CARDIAC CHEST PAIN 18 0.0057
157 INTERNATIONAL NORMALISED RATIO INCREASED 162 0.0057
158 CYTOMEGALOVIRUS COLITIS 13 0.0056
159 ATRIAL FLUTTER 45 0.0056
160 CATHETERISATION CARDIAC 25 0.0056
161 ATRIOVENTRICULAR BLOCK 43 0.0056
162 VASODILATATION 14 0.0056
163 RALES 32 0.0055
164 BLOOD PRESSURE SYSTOLIC DECREASED 25 0.0055
165 OLIGURIA 34 0.0055
166 NEUTROPENIC SEPSIS 39 0.0055
167 CAROTID ARTERY STENOSIS 19 0.0054
168 DEHYDRATION 720 0.0054
169 PULMONARY OEDEMA 237 0.0053
170 TRICUSPID VALVE INCOMPETENCE 42 0.0053
171 INTESTINAL ISCHAEMIA 29 0.0053
172 DIVERTICULUM INTESTINAL 23 0.0053
173 ATRIOVENTRICULAR BLOCK COMPLETE 35 0.0052
174 DIVERTICULUM 37 0.0052
175 HEART RATE INCREASED 515 0.0052
176 CARDIOGENIC SHOCK 74 0.0052
177 CORONARY ARTERIAL STENT INSERTION 26 0.0051
178 WRONG PATIENT RECEIVED PRODUCT 15 0.0051
179 SUBDURAL HAEMORRHAGE 14 0.0051
180 ARTERIOSCLEROSIS 48 0.0051
181 POTENTIATING DRUG INTERACTION 17 0.0051
182 PALPITATIONS 592 0.0050
183 CIRCULATORY COLLAPSE 86 0.0050
184 GLOMERULAR FILTRATION RATE DECREASED 62 0.0050
185 CARDIOMEGALY 62 0.0050
186 SUPRAVENTRICULAR EXTRASYSTOLES 17 0.0050
187 DIABETES MELLITUS INADEQUATE CONTROL 89 0.0050
188 BUNDLE BRANCH BLOCK RIGHT 23 0.0050
189 HYPOGLYCAEMIA 243 0.0050
190 ANAL HAEMORRHAGE 14 0.0050
191 RENAL FAILURE 662 0.0050
192 VENTRICULAR HYPOKINESIA 16 0.0050
193 MUSCULAR WEAKNESS 563 0.0049
194 RENAL INJURY 147 0.0049
195 MYOSITIS 44 0.0049
196 INTENTIONAL PRODUCT MISUSE 429 0.0049
197 ATRIAL FIBRILLATION 476 0.0049
198 HYPERURICAEMIA 20 0.0049
199 HYPERLACTACIDAEMIA 13 0.0048
200 ELECTROLYTE IMBALANCE 56 0.0048
201 VENTRICULAR EXTRASYSTOLES 50 0.0048
202 HIGH DENSITY LIPOPROTEIN DECREASED 16 0.0048
203 DEMENTIA 134 0.0048
204 HYPOTENSION 960 0.0048
205 AZOTAEMIA 19 0.0048
206 CLOSTRIDIAL INFECTION 16 0.0047
207 COMMUNICATION DISORDER 18 0.0047
208 CHOLECYSTITIS 56 0.0047
209 SUDDEN CARDIAC DEATH 16 0.0047
210 DRUG INTERACTION 742 0.0047
211 LEFT VENTRICULAR HYPERTROPHY 20 0.0047
212 AORTIC ARTERIOSCLEROSIS 12 0.0047
213 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 19 0.0046
214 CEREBROVASCULAR DISORDER 14 0.0046
215 ATRIOVENTRICULAR BLOCK SECOND DEGREE 14 0.0046
216 MOTOR DYSFUNCTION 47 0.0046
217 GASTROINTESTINAL HAEMORRHAGE 381 0.0046
218 HYPOCALCAEMIA 86 0.0045
219 BRAIN NATRIURETIC PEPTIDE INCREASED 14 0.0045
220 HYPERLIPIDAEMIA 54 0.0045
221 VASCULAR GRAFT 13 0.0045
222 FEMORAL NECK FRACTURE 23 0.0045
223 INITIAL INSOMNIA 46 0.0045
224 SYNCOPE 447 0.0045
225 BREAST SWELLING 12 0.0045
226 EMPHYSEMA 45 0.0045
227 PROTEIN URINE PRESENT 22 0.0044
228 MONOCYTE COUNT INCREASED 16 0.0044
229 MIGRAINE 420 0.0044
230 TROPONIN INCREASED 33 0.0043
231 LEFT VENTRICULAR DYSFUNCTION 29 0.0043
232 DIABETIC FOOT 13 0.0042
233 PERIPHERAL SWELLING 648 0.0042
234 BLOOD PRESSURE DIASTOLIC DECREASED 31 0.0042
235 HYPERHIDROSIS 540 0.0042
236 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 218 0.0042
237 PULMONARY CONGESTION 55 0.0042
238 VISUAL IMPAIRMENT 515 0.0042
239 VITAMIN D DEFICIENCY 40 0.0041
240 ACUTE PULMONARY OEDEMA 23 0.0041
241 BLADDER PAIN 13 0.0041
242 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
243 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
244 FUNCTIONAL GASTROINTESTINAL DISORDER 14 0.0040
245 HAEMORRHOIDS 79 0.0040
246 DIALYSIS 57 0.0040
247 MUSCLE RIGIDITY 48 0.0040
248 HYPERTHYROIDISM 58 0.0040
249 GASTRIC ULCER HAEMORRHAGE 22 0.0040
250 AUTOIMMUNE THYROIDITIS 15 0.0040
251 ANOREXIA 51 0.0040
252 INTERNATIONAL NORMALISED RATIO DECREASED 16 0.0039
253 HAEMORRHAGE SUBCUTANEOUS 14 0.0039
254 OESOPHAGITIS 43 0.0039
255 IMMUNE THROMBOCYTOPENIA 18 0.0039
256 MEMORY IMPAIRMENT 540 0.0039
257 SKIN WEEPING 14 0.0039
258 HYPOTONIA 39 0.0039
259 INTENTIONAL PRODUCT USE ISSUE 341 0.0039
260 RECTAL HAEMORRHAGE 167 0.0039
261 BLOOD CREATININE INCREASED 252 0.0039
262 SHOCK 88 0.0038
263 BLOOD PRESSURE DECREASED 252 0.0038
264 POLYURIA 31 0.0038
265 APLASIA PURE RED CELL 13 0.0038
266 RENAL IMPAIRMENT 317 0.0038
267 RENAL TUBULAR NECROSIS 37 0.0038
268 HYPOKALAEMIA 174 0.0038
269 OESOPHAGEAL CANDIDIASIS 15 0.0038
270 AORTIC VALVE INCOMPETENCE 16 0.0038
271 MULTI-ORGAN FAILURE 65 0.0038
272 LIVER FUNCTION TEST ABNORMAL 108 0.0037
273 COLITIS ISCHAEMIC 25 0.0037
274 HYPERVOLAEMIA 18 0.0036
275 OESOPHAGEAL ULCER 14 0.0036
276 DYSPNOEA EXERTIONAL 137 0.0036
277 MULTIPLE DRUG OVERDOSE 18 0.0036
278 DIZZINESS POSTURAL 35 0.0036
279 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 37 0.0036
280 HAEMORRHAGIC STROKE 28 0.0036
281 PULSE ABSENT 17 0.0036
282 URINARY RETENTION 119 0.0036
283 ARTERIAL OCCLUSIVE DISEASE 28 0.0036
284 HEPATITIS ACUTE 23 0.0035
285 DRY SKIN 470 0.0035
286 BLOOD CREATINE PHOSPHOKINASE INCREASED 101 0.0035
287 CEREBRAL ISCHAEMIA 18 0.0035
288 ANURIA 30 0.0035
289 MULTIPLE ORGAN DYSFUNCTION SYNDROME 98 0.0035
290 HAEMODIALYSIS 29 0.0034
291 STAPHYLOCOCCAL BACTERAEMIA 15 0.0034
292 HAEMOPTYSIS 96 0.0034
293 FLUID OVERLOAD 50 0.0034
294 RENAL CYST 27 0.0034
295 INCOHERENT 22 0.0034
296 ABDOMINAL DISCOMFORT 563 0.0034
297 DYSLIPIDAEMIA 17 0.0033
298 PROTHROMBIN TIME PROLONGED 20 0.0033
299 OSTEOPOROSIS 137 0.0033
300 FAECAL INCONTINENCE 16 0.0033
301 PROCEDURAL HAEMORRHAGE 13 0.0033
302 LARGE INTESTINE POLYP 23 0.0033
303 ISCHAEMIC STROKE 59 0.0033
304 BLOOD URIC ACID INCREASED 19 0.0033
305 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 29 0.0033
306 BLOOD GLUCOSE INCREASED 618 0.0033
307 BLOOD ALBUMIN DECREASED 26 0.0033
308 HAEMATEMESIS 83 0.0033
309 TUBULOINTERSTITIAL NEPHRITIS 61 0.0033
310 OEDEMA PERIPHERAL 394 0.0032
311 DIABETIC NEUROPATHY 16 0.0032
312 BLOOD PRESSURE SYSTOLIC INCREASED 63 0.0032
313 FAECES DISCOLOURED 70 0.0032
314 ACUTE RESPIRATORY FAILURE 62 0.0032
315 ABDOMINAL TENDERNESS 16 0.0032
316 HEART RATE DECREASED 113 0.0032
317 NEPHROPATHY 30 0.0032
318 POLYP 21 0.0032
319 URINE OUTPUT DECREASED 28 0.0032
320 PEMPHIGOID 24 0.0032
321 ARRHYTHMIA 150 0.0032
322 SPUTUM DISCOLOURED 30 0.0032
323 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 16 0.0032
324 CARDIAC VALVE DISEASE 18 0.0031
325 RIGHT VENTRICULAR FAILURE 22 0.0031
326 BLOOD SODIUM DECREASED 59 0.0031
327 MYOPATHY 27 0.0031
328 HYPERCHOLESTEROLAEMIA 30 0.0031
329 MYOCLONUS 37 0.0031
330 COVID-19 542 0.0031
331 ABDOMINAL PAIN UPPER 635 0.0031
332 SUBDURAL HAEMATOMA 44 0.0031
333 SPINAL OSTEOARTHRITIS 27 0.0031
334 DYSURIA 113 0.0031
335 EYE MOVEMENT DISORDER 21 0.0031
336 PETECHIAE 32 0.0031
337 ELECTROCARDIOGRAM QT PROLONGED 110 0.0031
338 HYPERTENSIVE CRISIS 34 0.0031
339 PLEURAL EFFUSION 184 0.0030
340 IMPAIRED GASTRIC EMPTYING 41 0.0030
341 BACK PAIN 697 0.0030
342 GASTRIC ULCER 57 0.0030
343 BODY HEIGHT DECREASED 32 0.0030
344 CARDIAC ARREST 247 0.0030
345 DIZZINESS 1487 0.0030
346 PRODUCT SOLUBILITY ABNORMAL 15 0.0030
347 DELIRIUM 103 0.0030
348 MELANOCYTIC NAEVUS 13 0.0030
349 CORONARY ARTERY BYPASS 17 0.0030
350 GOUT 53 0.0030
351 OBESITY 47 0.0029
352 HAEMORRHAGE INTRACRANIAL 44 0.0029
353 HAEMATOMA 76 0.0029
354 ILEUS PARALYTIC 13 0.0029
355 HYPERGLYCAEMIA 106 0.0029
356 AORTIC ANEURYSM 22 0.0029
357 FLUID RETENTION 147 0.0029
358 CARDIAC MURMUR 25 0.0029
359 TENDERNESS 30 0.0029
360 GASTRITIS 75 0.0028
361 SPRUE-LIKE ENTEROPATHY 14 0.0028
362 PLATELET COUNT INCREASED 37 0.0028
363 LUNG INFILTRATION 25 0.0028
364 CEREBRAL INFARCTION 69 0.0028
365 DYSPNOEA 1591 0.0028
366 CHOLELITHIASIS 92 0.0028
367 HYDRONEPHROSIS 21 0.0028
368 TORSADE DE POINTES 22 0.0028
369 FLUID INTAKE REDUCED 14 0.0028
370 CONTUSION 269 0.0028
371 ATAXIA 33 0.0028
372 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
373 CARDIAC DISORDER 258 0.0028
374 LOWER RESPIRATORY TRACT INFECTION 125 0.0027
375 CELLULITIS 138 0.0027
376 WHITE BLOOD CELL COUNT INCREASED 105 0.0027
377 NEUTROPHIL COUNT INCREASED 28 0.0027
378 TYPE 2 DIABETES MELLITUS 92 0.0027
379 HAEMOGLOBIN DECREASED 280 0.0027
380 SLEEP APNOEA SYNDROME 52 0.0027
381 BLOOD LACTATE DEHYDROGENASE INCREASED 43 0.0027
382 UROSEPSIS 25 0.0027
383 MULTIPLE INJURIES 17 0.0027
384 HEART RATE IRREGULAR 61 0.0027
385 HUMERUS FRACTURE 13 0.0027
386 MUSCLE ATROPHY 34 0.0027
387 CYANOSIS 42 0.0027
388 MEDICATION ERROR 148 0.0027
389 BLOOD PRESSURE INADEQUATELY CONTROLLED 16 0.0027
390 CHOLECYSTITIS ACUTE 15 0.0026
391 CHEST DISCOMFORT 271 0.0026
392 CONJUNCTIVITIS 49 0.0026
393 EJECTION FRACTION DECREASED 41 0.0026
394 EPISTAXIS 197 0.0026
395 MENTAL STATUS CHANGES 73 0.0026
396 HAEMATOCRIT DECREASED 52 0.0026
397 LEUKOCYTOSIS 47 0.0026
398 FALL 863 0.0026
399 PRODUCT QUALITY ISSUE 349 0.0026
400 PSEUDOMONAS INFECTION 22 0.0026
401 CARDIAC OPERATION 22 0.0026
402 SEDATION 67 0.0026
403 NOCTURIA 31 0.0026
404 BLISTER 143 0.0025
405 HEMIPARESIS 43 0.0025
406 PRODUCT ADMINISTRATION ERROR 51 0.0025
407 ANAEMIA 481 0.0025
408 MOUTH ULCERATION 53 0.0025
409 HALLUCINATION, VISUAL 53 0.0025
410 INSOMNIA 665 0.0025
411 ALOPECIA 490 0.0025
412 INFARCTION 17 0.0025
413 CHROMATURIA 56 0.0025
414 CARDIAC FLUTTER 16 0.0025
415 DISORIENTATION 98 0.0025
416 CONFUSIONAL STATE 399 0.0025
417 FEELING ABNORMAL 590 0.0025
418 HYPOTHYROIDISM 78 0.0024
419 BLOOD MAGNESIUM DECREASED 21 0.0024
420 GENERALISED OEDEMA 30 0.0024
421 ELECTROCARDIOGRAM ABNORMAL 19 0.0024
422 HEAD INJURY 76 0.0024
423 GASTROOESOPHAGEAL REFLUX DISEASE 193 0.0024
424 SKIN LACERATION 26 0.0024
425 RESPIRATORY DISORDER 71 0.0024
426 HAEMATURIA 81 0.0024
427 LETHARGY 136 0.0024
428 ACIDOSIS 18 0.0024
429 HEPATOMEGALY 23 0.0023
430 BLOOD POTASSIUM DECREASED 70 0.0023
431 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
432 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
433 LACTIC ACIDOSIS 75 0.0023
434 ECONOMIC PROBLEM 35 0.0023
435 HEPATIC STEATOSIS 43 0.0023
436 URINARY INCONTINENCE 68 0.0023
437 UNRESPONSIVE TO STIMULI 59 0.0023
438 DYSARTHRIA 86 0.0023
439 ASPIRATION 25 0.0023
440 GROIN PAIN 20 0.0023
441 ATELECTASIS 22 0.0023
442 SWOLLEN TONGUE 71 0.0023
443 OEDEMA 123 0.0023
444 ANXIETY 645 0.0023
445 RENAL PAIN 24 0.0023
446 SKIN ULCER 58 0.0022
447 FLANK PAIN 21 0.0022
448 POST PROCEDURAL HAEMORRHAGE 26 0.0022
449 JAUNDICE 60 0.0022
450 HYPERTRIGLYCERIDAEMIA 13 0.0022
451 COLD SWEAT 39 0.0022
452 BLOOD URINE PRESENT 42 0.0022
453 DECUBITUS ULCER 18 0.0022
454 RESTLESS LEGS SYNDROME 40 0.0022
455 METABOLIC ACIDOSIS 70 0.0022
456 PERIPHERAL COLDNESS 30 0.0022
457 CARDIAC PACEMAKER INSERTION 13 0.0022
458 PANCREATITIS ACUTE 49 0.0022
459 HAEMOGLOBIN ABNORMAL 14 0.0022
460 DRUG LEVEL INCREASED 36 0.0022
461 CARDIOMYOPATHY 32 0.0022
462 COAGULOPATHY 36 0.0022
463 PULMONARY HYPERTENSION 45 0.0022
464 HEPATITIS CHOLESTATIC 13 0.0022
465 GANGRENE 13 0.0022
466 MALAISE 945 0.0022
467 LOCALISED INFECTION 52 0.0021
468 FULL BLOOD COUNT DECREASED 43 0.0021
469 VOMITING 998 0.0021
470 BLOOD GLUCOSE FLUCTUATION 23 0.0021
471 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
472 RESTLESSNESS 76 0.0021
473 URINARY TRACT INFECTION 354 0.0021
474 CANDIDA INFECTION 35 0.0021
475 LOSS OF CONSCIOUSNESS 265 0.0021
476 HYPERTENSION 437 0.0021
477 CLOSTRIDIUM DIFFICILE INFECTION 45 0.0021
478 DIARRHOEA 1330 0.0021
479 RENAL DISORDER 96 0.0021
480 MOBILITY DECREASED 147 0.0020
481 ECCHYMOSIS 14 0.0020
482 PRURITUS 780 0.0020
483 HYPOXIA 71 0.0020
484 WEIGHT FLUCTUATION 21 0.0020
485 SEPSIS 222 0.0020
486 BRADYPHRENIA 13 0.0020
487 HIP FRACTURE 64 0.0020
488 RESPIRATORY FAILURE 145 0.0020
489 KIDNEY INFECTION 39 0.0020
490 BEDRIDDEN 26 0.0020
491 ORAL CANDIDIASIS 26 0.0020
492 DYSPEPSIA 193 0.0020
493 PNEUMONIA BACTERIAL 18 0.0020
494 MYALGIA 332 0.0020
495 GRAND MAL CONVULSION 18 0.0019
496 DECREASED ACTIVITY 21 0.0019
497 COLON CANCER 29 0.0019
498 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
499 PYREXIA 672 0.0019
500 INCORRECT PRODUCT ADMINISTRATION DURATION 42 0.0019
501 ARTHRALGIA 806 0.0019
502 COORDINATION ABNORMAL 27 0.0019
503 MASS 27 0.0019
504 BODY TEMPERATURE DECREASED 19 0.0019
505 BRONCHIECTASIS 13 0.0019
506 ULCER HAEMORRHAGE 13 0.0019
507 HYPOPHAGIA 49 0.0019
508 MULTIPLE ALLERGIES 15 0.0019
509 BLOOD PRESSURE ABNORMAL 38 0.0019
510 PALLOR 52 0.0019
511 SEASONAL ALLERGY 27 0.0019
512 ABNORMAL LOSS OF WEIGHT 13 0.0019
513 TOOTH FRACTURE 21 0.0019
514 GLYCOSYLATED HAEMOGLOBIN INCREASED 48 0.0019
515 SCHIZOPHRENIA 23 0.0019
516 STEVENS-JOHNSON SYNDROME 42 0.0019
517 ABNORMAL DREAMS 52 0.0019
518 BLOOD DISORDER 15 0.0019
519 LYMPHOCYTE COUNT DECREASED 33 0.0019
520 ANHEDONIA 49 0.0019
521 PNEUMONIA 601 0.0019
522 BLOOD IRON DECREASED 22 0.0019
523 CEREBRAL HAEMORRHAGE 66 0.0018
524 ASTHENIA 692 0.0018
525 POOR VENOUS ACCESS 19 0.0018
526 BLOOD PRESSURE FLUCTUATION 44 0.0018
527 ABNORMAL FAECES 15 0.0018
528 ADVERSE DRUG REACTION 164 0.0018
529 BLOOD CALCIUM INCREASED 16 0.0018
530 HOSPICE CARE 18 0.0018
531 BALANCE DISORDER 157 0.0018
532 PULMONARY MASS 27 0.0018
533 DIABETES MELLITUS 138 0.0018
534 APPETITE DISORDER 12 0.0018
535 LUNG INFECTION 28 0.0018
536 RIB FRACTURE 37 0.0018
537 INCONTINENCE 19 0.0018
538 SPINAL FRACTURE 36 0.0018
539 SUDDEN DEATH 19 0.0018
540 MALNUTRITION 20 0.0018
541 TOXIC SKIN ERUPTION 18 0.0018
542 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
543 TENDON RUPTURE 22 0.0018
544 BLOOD CALCIUM DECREASED 20 0.0018
545 RASH ERYTHEMATOUS 85 0.0018
546 MOUTH HAEMORRHAGE 13 0.0018
547 PULMONARY FIBROSIS 34 0.0018
548 BLOOD ALKALINE PHOSPHATASE INCREASED 44 0.0018
549 PRODUCTIVE COUGH 84 0.0018
550 HYPOPHOSPHATAEMIA 13 0.0018
551 ACUTE HEPATIC FAILURE 24 0.0018
552 INTERNAL HAEMORRHAGE 20 0.0017
553 HEADACHE 1095 0.0017
554 CARDIOVASCULAR DISORDER 44 0.0017
555 PYELONEPHRITIS 15 0.0017
556 CONSTIPATION 376 0.0017
557 HAEMATOCHEZIA 95 0.0017
558 OSTEOMYELITIS 31 0.0017
559 FATIGUE 1328 0.0017
560 LACERATION 16 0.0017
561 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
562 DIVERTICULITIS 47 0.0017
563 PURPURA 15 0.0017
564 COVID-19 PNEUMONIA 20 0.0017
565 LOW DENSITY LIPOPROTEIN INCREASED 13 0.0017
566 TENDONITIS 26 0.0017
567 HYPOALBUMINAEMIA 13 0.0017
568 COUGH 468 0.0017
569 WRIST FRACTURE 20 0.0017
570 RESPIRATORY DISTRESS 46 0.0017
571 SEROTONIN SYNDROME 32 0.0017
572 ALANINE AMINOTRANSFERASE INCREASED 102 0.0017
573 DERMATITIS BULLOUS 12 0.0017
574 DRUG-INDUCED LIVER INJURY 52 0.0017
575 LUPUS-LIKE SYNDROME 15 0.0017
576 CEREBROVASCULAR ACCIDENT 280 0.0017
577 NAUSEA 1301 0.0016
578 WOUND INFECTION 18 0.0016
579 DEPRESSED LEVEL OF CONSCIOUSNESS 65 0.0016
580 STAPHYLOCOCCAL INFECTION 54 0.0016
581 INTENTIONAL OVERDOSE 105 0.0016
582 RESPIRATORY ARREST 45 0.0016
583 INCREASED TENDENCY TO BRUISE 15 0.0016
584 MUSCULOSKELETAL DISCOMFORT 28 0.0016
585 RED BLOOD CELL SEDIMENTATION RATE INCREASED 18 0.0016
586 PLATELET COUNT DECREASED 173 0.0016
587 SINUS TACHYCARDIA 23 0.0016
588 SKIN DISORDER 54 0.0016
589 ACTIVITIES OF DAILY LIVING IMPAIRED 32 0.0016
590 DRUG TOXICITY 22 0.0016
591 BRONCHOSPASM 23 0.0016
592 SCRATCH 17 0.0016
593 RED BLOOD CELL COUNT DECREASED 46 0.0016
594 BLOOD CHOLESTEROL INCREASED 75 0.0016
595 MUSCLE DISORDER 13 0.0016
596 DIARRHOEA HAEMORRHAGIC 15 0.0016
597 PERITONITIS BACTERIAL 16 0.0016
598 SKIN CANCER 34 0.0016
599 BLOOD PRESSURE INCREASED 241 0.0016
600 DRY THROAT 16 0.0016
601 MUSCLE SPASMS 288 0.0016
602 WHEEZING 93 0.0016
603 BOWEL MOVEMENT IRREGULARITY 12 0.0016
604 HEPATITIS 40 0.0016
605 MYDRIASIS 20 0.0016
606 NECK PAIN 87 0.0016
607 ANAL INCONTINENCE 14 0.0016
608 CARDIO-RESPIRATORY ARREST 65 0.0016
609 OXYGEN SATURATION DECREASED 87 0.0015
610 HEPATIC CIRRHOSIS 29 0.0015
611 GAMMA-GLUTAMYLTRANSFERASE INCREASED 34 0.0015
612 SKIN LESION 42 0.0015
613 CATARACT 91 0.0015
614 PROSTATIC SPECIFIC ANTIGEN INCREASED 21 0.0015
615 VITAMIN D DECREASED 13 0.0015
616 PAIN IN JAW 43 0.0015
617 C-REACTIVE PROTEIN INCREASED 55 0.0015
618 THROMBOCYTOPENIA 169 0.0015
619 BLADDER DISORDER 15 0.0015
620 POST PROCEDURAL COMPLICATION 29 0.0015
621 ERYTHEMA MULTIFORME 14 0.0015
622 PHARYNGEAL OEDEMA 23 0.0015
623 SQUAMOUS CELL CARCINOMA 14 0.0015
624 ASPARTATE AMINOTRANSFERASE INCREASED 79 0.0015
625 PAIN 908 0.0015
626 GASTRIC HAEMORRHAGE 17 0.0015
627 TACHYPNOEA 20 0.0015
628 SEPTIC SHOCK 64 0.0015
629 PERICARDIAL EFFUSION 34 0.0015
630 SPEECH DISORDER 77 0.0015
631 LUNG DISORDER 72 0.0015
632 HEAD DISCOMFORT 26 0.0015
633 DRUG ERUPTION 26 0.0015
634 RESPIRATORY RATE INCREASED 13 0.0015
635 DEPRESSED MOOD 77 0.0015
636 HAEMARTHROSIS 13 0.0014
637 PNEUMOTHORAX 23 0.0014
638 INTERSTITIAL LUNG DISEASE 70 0.0014
639 HAEMORRHAGE 151 0.0014
640 LIVER FUNCTION TEST INCREASED 31 0.0014
641 DYSSTASIA 42 0.0014
642 PHARYNGEAL SWELLING 14 0.0014
643 NEPHROPATHY TOXIC 16 0.0014
644 MACULAR DEGENERATION 17 0.0014
645 BODY TEMPERATURE INCREASED 29 0.0014
646 RESPIRATORY TRACT INFECTION 37 0.0014
647 CYSTITIS 45 0.0014
648 FEAR 38 0.0014
649 ANAPHYLACTIC REACTION 78 0.0014
650 PNEUMONIA ASPIRATION 35 0.0014
651 SKIN DISCOLOURATION 64 0.0014
652 TREMOR 231 0.0014
653 DEPRESSION 315 0.0014
654 EYE PAIN 78 0.0014
655 SCIATICA 22 0.0014
656 FLATULENCE 78 0.0014
657 PAIN IN EXTREMITY 402 0.0014
658 GASTROINTESTINAL DISORDER 122 0.0014
659 MUSCLE TIGHTNESS 22 0.0014
660 BLOOD TEST ABNORMAL 19 0.0014
661 DELUSION 21 0.0014
662 WEIGHT DECREASED 377 0.0013
663 ERUCTATION 26 0.0013
664 PRURITUS GENERALISED 29 0.0013
665 BACTERIAL INFECTION 25 0.0013
666 TRANSFUSION 14 0.0013
667 SWELLING FACE 87 0.0013
668 BLOOD GLUCOSE DECREASED 64 0.0013
669 BLOOD BILIRUBIN INCREASED 36 0.0013
670 DECREASED APPETITE 308 0.0013
671 DEEP VEIN THROMBOSIS 86 0.0013
672 IMPAIRED QUALITY OF LIFE 19 0.0013
673 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
674 POLLAKIURIA 55 0.0013
675 PROTEINURIA 25 0.0013
676 LIGAMENT SPRAIN 13 0.0013
677 CHOLECYSTECTOMY 15 0.0013
678 SINUS DISORDER 26 0.0013
679 ABDOMINAL PAIN 304 0.0013
680 DYSPHAGIA 124 0.0013
681 ABDOMINAL DISTENSION 136 0.0013
682 MUSCULOSKELETAL PAIN 68 0.0013
683 BRONCHITIS 96 0.0013
684 GAIT DISTURBANCE 248 0.0013
685 ABASIA 32 0.0013
686 BACK INJURY 14 0.0013
687 MIDDLE INSOMNIA 24 0.0013
688 TOOTH ABSCESS 13 0.0013
689 RASH PRURITIC 69 0.0013
690 DRY MOUTH 103 0.0013
691 FEMUR FRACTURE 39 0.0013
692 SINUS CONGESTION 17 0.0013
693 BURNING SENSATION 88 0.0013
694 BLOOD COUNT ABNORMAL 19 0.0013
695 DRUG PRESCRIBING ERROR 24 0.0012
696 DIABETIC KETOACIDOSIS 30 0.0012
697 BLOOD GLUCOSE ABNORMAL 23 0.0012
698 NEURALGIA 30 0.0012
699 HEPATIC FUNCTION ABNORMAL 46 0.0012
700 CONDITION AGGRAVATED 373 0.0012
701 SCAR 21 0.0012
702 MICTURITION URGENCY 14 0.0012
703 ASCITES 36 0.0012
704 LIVER INJURY 30 0.0012
705 EATING DISORDER 26 0.0012
706 HERPES ZOSTER 70 0.0012
707 JOINT INJURY 26 0.0012
708 MOVEMENT DISORDER 39 0.0012
709 HYPOACUSIS 52 0.0012
710 PERITONITIS 25 0.0012
711 TREATMENT NONCOMPLIANCE 66 0.0012
712 PRODUCT USE COMPLAINT 19 0.0012
713 RASH 524 0.0012
714 EYE HAEMORRHAGE 16 0.0012
715 TOXICITY TO VARIOUS AGENTS 202 0.0012
716 CHOLESTASIS 23 0.0012
717 RESPIRATORY TRACT CONGESTION 19 0.0012
718 LIMB DISCOMFORT 37 0.0012
719 PHARMACEUTICAL PRODUCT COMPLAINT 31 0.0012
720 PULMONARY THROMBOSIS 13 0.0012
721 WHITE BLOOD CELL COUNT DECREASED 129 0.0012
722 EAR PAIN 23 0.0012
723 ARTHRITIS 93 0.0012
724 OSTEOARTHRITIS 50 0.0012
725 DRUG DISPENSING ERROR 18 0.0012
726 UNEVALUABLE EVENT 89 0.0012
727 THIRST 21 0.0012
728 PANCREATITIS 62 0.0012
729 GINGIVAL BLEEDING 16 0.0012
730 THROMBOSIS 94 0.0012
731 GASTROENTERITIS 17 0.0012
732 GENERAL PHYSICAL HEALTH DETERIORATION 134 0.0012
733 VISION BLURRED 159 0.0012
734 PANIC ATTACK 42 0.0012
735 RASH MACULAR 40 0.0011
736 COMPLETED SUICIDE 95 0.0011
737 SCAB 13 0.0011
738 DEVICE OCCLUSION 16 0.0011
739 AGRANULOCYTOSIS 21 0.0011
740 ERECTILE DYSFUNCTION 29 0.0011
741 BREAST PAIN 12 0.0011
742 NEUROPATHY PERIPHERAL 107 0.0011
743 SENSORY DISTURBANCE 18 0.0011
744 HAIR TEXTURE ABNORMAL 15 0.0011
745 GALLBLADDER DISORDER 20 0.0011
746 LABORATORY TEST ABNORMAL 33 0.0011
747 THERAPY NON-RESPONDER 50 0.0011
748 GASTROENTERITIS VIRAL 20 0.0011
749 DYSKINESIA 45 0.0011
750 MYELODYSPLASTIC SYNDROME 16 0.0011
751 LIVER DISORDER 49 0.0011
752 HYPOKINESIA 16 0.0011
753 CONVULSION 63 0.0011
754 ENCEPHALOPATHY 27 0.0011
755 VERTIGO 67 0.0011
756 RHINORRHOEA 71 0.0011
757 ANKLE FRACTURE 17 0.0011
758 NIGHTMARE 38 0.0011
759 BACTERAEMIA 13 0.0011
760 PRODUCT PRESCRIBING ERROR 26 0.0011
761 OFF LABEL USE 951 0.0011
762 VISUAL ACUITY REDUCED 36 0.0011
763 RASH GENERALISED 28 0.0011
764 OROPHARYNGEAL PAIN 100 0.0011
765 NASAL CONGESTION 63 0.0011
766 ULCER 17 0.0011
767 HYPOAESTHESIA 159 0.0011
768 AGITATION 78 0.0011
769 SWELLING 99 0.0011
770 PANCYTOPENIA 59 0.0011
771 SPINAL OPERATION 13 0.0011
772 NIGHT SWEATS 34 0.0011
773 COLITIS 40 0.0011
774 SOMNOLENCE 212 0.0011
775 ASTHMA 119 0.0011
776 COMA 50 0.0010
777 PHARYNGITIS 13 0.0010
778 HYPERSOMNIA 30 0.0010
779 DEVICE RELATED INFECTION 16 0.0010
780 HOT FLUSH 78 0.0010
781 LIMB INJURY 28 0.0010
782 ILLNESS 106 0.0010
783 PNEUMONITIS 28 0.0010
784 HEPATIC FAILURE 31 0.0010
785 ACUTE MYELOID LEUKAEMIA 16 0.0010
786 LACRIMATION INCREASED 31 0.0010
787 INJURY 72 0.0010
788 SKIN EXFOLIATION 86 0.0010
789 DYSPHONIA 59 0.0010
790 HALLUCINATION, AUDITORY 16 0.0010
791 INTERVERTEBRAL DISC PROTRUSION 22 0.0010
792 EYE DISORDER 33 0.0010
793 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 17 0.0010
794 LUNG NEOPLASM MALIGNANT 41 0.0010
795 EYE SWELLING 37 0.0010
796 DEAFNESS 26 0.0010
797 TOOTHACHE 18 0.0010
798 JOINT SWELLING 120 0.0010
799 SKIN REACTION 14 0.0010
800 ECZEMA 52 0.0010
801 ERYTHEMA 204 0.0010
802 VIRAL INFECTION 33 0.0010
803 LYMPHADENOPATHY 35 0.0010
804 BONE DISORDER 18 0.0010
805 FEEDING DISORDER 20 0.0010
806 TASTE DISORDER 20 0.0010
807 BACK DISORDER 16 0.0010
808 GLOSSODYNIA 22 0.0010
809 ORAL PAIN 22 0.0010
810 THROAT IRRITATION 44 0.0010
811 DRUG ADMINISTRATION ERROR 30 0.0010
812 UPPER RESPIRATORY TRACT INFECTION 45 0.0010
813 CHOKING 19 0.0010
814 PARAESTHESIA ORAL 14 0.0010
815 EOSINOPHILIA 17 0.0010
816 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
817 WEIGHT INCREASED 217 0.0010
818 MENTAL DISORDER 42 0.0010
819 SLEEP DISORDER 68 0.0010
820 PRODUCT TASTE ABNORMAL 13 0.0010
821 AGGRESSION 48 0.0010
822 PULMONARY EMBOLISM 91 0.0010
823 PHOTOPHOBIA 18 0.0010
824 UPPER LIMB FRACTURE 19 0.0010
825 PRODUCT DOSE OMISSION 62 0.0009
826 FACE OEDEMA 16 0.0009
827 DRY EYE 47 0.0009
828 EMOTIONAL DISORDER 29 0.0009
829 LOWER LIMB FRACTURE 18 0.0009
830 CHILLS 109 0.0009
831 INTESTINAL OBSTRUCTION 35 0.0009
832 INFECTION 134 0.0009
833 INFLUENZA 103 0.0009
834 EPILEPSY 28 0.0009
835 THYROID DISORDER 14 0.0009
836 SUICIDE ATTEMPT 55 0.0009
837 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
838 MUSCULOSKELETAL CHEST PAIN 14 0.0009
839 GASTRIC DISORDER 31 0.0009
840 FEELING COLD 25 0.0009
841 GAIT INABILITY 30 0.0009
842 BRAIN FOG 14 0.0009
843 MUSCULOSKELETAL DISORDER 17 0.0009
844 THROAT TIGHTNESS 24 0.0009
845 GLAUCOMA 17 0.0009
846 HEPATIC ENZYME INCREASED 60 0.0009
847 AKATHISIA 12 0.0009
848 HOSPITALISATION 135 0.0009
849 SKIN HAEMORRHAGE 13 0.0009
850 INTENTIONAL DOSE OMISSION 25 0.0009
851 STOMATITIS 53 0.0009
852 PSORIASIS 113 0.0009
853 NERVOUSNESS 45 0.0009
854 HEPATOTOXICITY 19 0.0009
855 DISCOMFORT 52 0.0009
856 NEPHROLITHIASIS 39 0.0008
857 INSURANCE ISSUE 13 0.0008
858 RETCHING 18 0.0008
859 LEUKOPENIA 42 0.0008
860 ROAD TRAFFIC ACCIDENT 35 0.0008
861 FEELING HOT 51 0.0008
862 APHASIA 25 0.0008
863 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
864 APATHY 12 0.0008
865 EYE IRRITATION 47 0.0008
866 DEATH 699 0.0008
867 MUSCULOSKELETAL STIFFNESS 71 0.0008
868 PARAESTHESIA 127 0.0008
869 SNEEZING 18 0.0008
870 FEBRILE NEUTROPENIA 53 0.0008
871 METASTASES TO LIVER 14 0.0008
872 SEIZURE 92 0.0008
873 IRRITABLE BOWEL SYNDROME 17 0.0008
874 FRACTURE 15 0.0008
875 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 38 0.0008
876 ABDOMINAL PAIN LOWER 20 0.0008
877 NASOPHARYNGITIS 145 0.0008
878 NEUTROPHIL COUNT DECREASED 32 0.0008
879 THERAPY INTERRUPTED 56 0.0008
880 SINUSITIS 80 0.0008
881 NEUTROPENIA 106 0.0008
882 HYPERSENSITIVITY 144 0.0008
883 TOOTH LOSS 16 0.0008
884 PLASMA CELL MYELOMA 30 0.0008
885 PRODUCT DOSE OMISSION ISSUE 226 0.0008
886 SURGERY 45 0.0008
887 AGEUSIA 19 0.0008
888 PRODUCT USE ISSUE 143 0.0008
889 OCULAR HYPERAEMIA 36 0.0008
890 PARANOIA 13 0.0008
891 THINKING ABNORMAL 14 0.0008
892 MENTAL IMPAIRMENT 18 0.0007
893 PRODUCT USE IN UNAPPROVED INDICATION 184 0.0007
894 BONE MARROW FAILURE 15 0.0007
895 NERVOUS SYSTEM DISORDER 23 0.0007
896 FEELING JITTERY 14 0.0007
897 FLUSHING 74 0.0007
898 TRANSAMINASES INCREASED 16 0.0007
899 TOOTH DISORDER 16 0.0007
900 DRUG INTOLERANCE 69 0.0007
901 DRUG DOSE OMISSION 118 0.0007
902 DISEASE PROGRESSION 84 0.0007
903 OVERDOSE 146 0.0007
904 ILL-DEFINED DISORDER 41 0.0007
905 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 48 0.0007
906 TARDIVE DYSKINESIA 19 0.0007
907 ADVERSE EVENT 62 0.0007
908 HERNIA 13 0.0007
909 DERMATITIS 14 0.0007
910 WRONG TECHNIQUE IN DRUG USAGE PROCESS 24 0.0007
911 ANAPHYLACTIC SHOCK 17 0.0007
912 ARTHROPATHY 36 0.0006
913 OSTEONECROSIS OF JAW 16 0.0006
914 GYNAECOMASTIA 20 0.0006
915 IMPAIRED HEALING 21 0.0006
916 INFLAMMATION 33 0.0006
917 BONE PAIN 37 0.0006
918 PRODUCT SUBSTITUTION ISSUE 36 0.0006
919 WITHDRAWAL SYNDROME 26 0.0006
920 KNEE ARTHROPLASTY 13 0.0006
921 PROCEDURAL PAIN 17 0.0006
922 JOINT STIFFNESS 16 0.0006
923 CRYING 22 0.0006
924 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
925 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
926 PRODUCT DOSE OMISSION IN ERROR 17 0.0006
927 INFLUENZA LIKE ILLNESS 49 0.0006
928 SUICIDAL IDEATION 54 0.0006
929 DERMATITIS ATOPIC 31 0.0006
930 RASH MACULO-PAPULAR 13 0.0006
931 DYSGEUSIA 43 0.0006
932 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 104 0.0006
933 WOUND 16 0.0006
934 PRODUCT AVAILABILITY ISSUE 13 0.0006
935 EMOTIONAL DISTRESS 69 0.0006
936 NEOPLASM MALIGNANT 38 0.0006
937 INCORRECT DRUG ADMINISTRATION DURATION 16 0.0006
938 FREQUENT BOWEL MOVEMENTS 15 0.0006
939 DRUG ABUSE 46 0.0006
940 INCORRECT DOSE ADMINISTERED 124 0.0005
941 URTICARIA 91 0.0005
942 FUNGAL INFECTION 18 0.0005
943 UNDERDOSE 39 0.0005
944 ABNORMAL BEHAVIOUR 21 0.0005
945 EAR INFECTION 14 0.0005
946 PANCREATIC CARCINOMA 15 0.0005
947 THERAPEUTIC RESPONSE DECREASED 31 0.0005
948 PSYCHOTIC DISORDER 15 0.0005
949 DRUG RESISTANCE 13 0.0005
950 DRUG INEFFECTIVE 663 0.0005
951 DRUG EFFECT DECREASED 27 0.0005
952 IRRITABILITY 30 0.0005
953 INFUSION RELATED REACTION 33 0.0005
954 DRUG EFFECT INCOMPLETE 18 0.0005
955 THERAPEUTIC PRODUCT EFFECT DECREASED 22 0.0005
956 THERAPY CESSATION 25 0.0005
957 DRUG DEPENDENCE 78 0.0005
958 ANGER 16 0.0005
959 MOOD SWINGS 15 0.0005
960 MALIGNANT NEOPLASM PROGRESSION 48 0.0005
961 ACCIDENTAL OVERDOSE 17 0.0005
962 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
963 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
964 RHEUMATOID ARTHRITIS 47 0.0004
965 DEVICE MALFUNCTION 29 0.0004
966 INJECTION SITE MASS 15 0.0004
967 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 79 0.0004
968 DISEASE RECURRENCE 18 0.0004
969 NEOPLASM PROGRESSION 13 0.0004
970 PROSTATE CANCER 30 0.0004
971 VAGINAL HAEMORRHAGE 15 0.0003
972 BLADDER CANCER 20 0.0003
973 INJECTION SITE HAEMORRHAGE 27 0.0003
974 EXPOSURE DURING PREGNANCY 20 0.0003
975 PSORIATIC ARTHROPATHY 13 0.0003
976 INJECTION SITE PRURITUS 21 0.0003
977 INJECTION SITE BRUISING 24 0.0003
978 DEVICE ISSUE 26 0.0003
979 MULTIPLE SCLEROSIS 13 0.0003
980 ACNE 20 0.0003
981 INJECTION SITE REACTION 18 0.0003
982 INJECTION SITE PAIN 80 0.0003
983 INJECTION SITE SWELLING 18 0.0002
984 NO ADVERSE EVENT 42 0.0002
985 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
986 INJECTION SITE ERYTHEMA 27 0.0002
987 DRUG WITHDRAWAL SYNDROME 19 0.0002
988 TREATMENT FAILURE 17 0.0002
989 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
990 BREAST CANCER 18 0.0002
991 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
992 DEVICE DIFFICULT TO USE 12 0.0002
993 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002